- This event has passed.
Informatics Research Seminar: Regionalization and Trend Analyses of Health Service Utilization and Cost Among Autosomal Dominant Polycystic Kidney Disease Patients in the U.S.
September 12, 2018 @ 4:00 pm - 5:00 pm EDT
Speaker: Christopher Blanchette, PhD, MBA and Laura Clark, MS, RCEP
Presented from UNC-C
Broadcast Link: Seminar
Autosomal dominant polycystic kidney disease (ADPKD) involves fluid-filled cysts, progressive total
kidney volume and glomerular filtration rate decline to end-stage renal disease (ESRD). 50 to 70% of the
ADPKD population requires either renal dialysis or transplant by the 4th-6th decade of life. ESRD
imposes extreme physiological burden on patients and substantial economic burden on the US healthcare system. In this seminar, we will look at the objective, the results and the conclusion of a study done to evaluate the risk difference and crude rate of mortality in ADPKD-ESRD patients on dialysis or after transplant.
Christopher M. Blanchette, PhD, MBA is the Director of the Data Science Initiative and an Associate Professor of Public Health Sciences for the College of Health & Human Services at the University of North Carolina at Charlotte. He maintains adjunct appointments with the W.G. (Bill) Heffner VA Medical Center in Salisbury, NC as well as the Division of Pharmaceutical Outcomes and Policy with the University of North Carolina at Chapel Hill Eshelman School of Pharmacy and the Department of Pharmaceutical Marketing at the Saint Joseph’s University Erivan Haub School of Business. Dr. Blanchette’s research focuses on using Big Data to assess the clinical and economic outcomes associated with pharmaceutical use for chronic diseases. He was formerly a Principal & the Americas Leader for the Retrospective Outcomes Research Center of Excellence at IMS Health, directed the Division of Clinical & Outcomes Research at the Lovelace Respiratory Research Institute and served in payer marketing and health economics and outcomes research roles for GlaxoSmithKline, Otsuka America Pharmaceutical Inc., and the Premier Hospital Alliance.
Laura Clark, M.S., RCEP is currently a 3rd year PhD student in Health Services Research at UNC Charlotte. While working on her doctoral degree, she has lead a research program in health economics and outcomes for rare diseases focused on autosomal dominant polycystic kidney disease in the Health Analytics and Outcomes Research Academy (HAnORA). In addition to her own research, Laura also serves at the ISPOR student chapter president for UNC Charlotte. Previously, Laura completed an internship at Precision Health Economics providing consulting services to HEOR scientists in biopharmaceutical manufacturing. Prior to her doctoral studies, Laura’s experience includes years of clinical engagement in cardiovascular, pulmonary and oncology healthcare. Laura has a M.S in Kinesiology from UNC Charlotte and certification as a Registered Clinical Exercise Physiologist in the American College of Sports Medicine.